- Home
- YIBO vs IGMS Comparison
YIBO vs IGMS Comparison
Compare YIBO & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- IGMS
- Stock Information
- Founded
- YIBO 2011
- IGMS 1993
- Country
- YIBO China
- IGMS United States
- Employees
- YIBO N/A
- IGMS N/A
- Industry
- YIBO
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- YIBO
- IGMS Health Care
- Exchange
- YIBO NYSE
- IGMS Nasdaq
- Market Cap
- YIBO 81.8M
- IGMS 81.9M
- IPO Year
- YIBO 2024
- IGMS 2019
- Fundamental
- Price
- YIBO $1.46
- IGMS $1.27
- Analyst Decision
- YIBO
- IGMS Hold
- Analyst Count
- YIBO 0
- IGMS 8
- Target Price
- YIBO N/A
- IGMS $6.00
- AVG Volume (30 Days)
- YIBO 26.6K
- IGMS 1.3M
- Earning Date
- YIBO 09-13-2025
- IGMS 08-13-2025
- Dividend Yield
- YIBO N/A
- IGMS N/A
- EPS Growth
- YIBO N/A
- IGMS N/A
- EPS
- YIBO 0.13
- IGMS N/A
- Revenue
- YIBO $149,828,000.00
- IGMS $2,681,000.00
- Revenue This Year
- YIBO N/A
- IGMS $252.44
- Revenue Next Year
- YIBO N/A
- IGMS $46.48
- P/E Ratio
- YIBO $11.35
- IGMS N/A
- Revenue Growth
- YIBO N/A
- IGMS 27.36
- 52 Week Low
- YIBO $0.95
- IGMS $0.92
- 52 Week High
- YIBO $17.47
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- YIBO 49.79
- IGMS 48.73
- Support Level
- YIBO $1.35
- IGMS $1.26
- Resistance Level
- YIBO $1.55
- IGMS $1.37
- Average True Range (ATR)
- YIBO 0.09
- IGMS 0.03
- MACD
- YIBO 0.00
- IGMS -0.01
- Stochastic Oscillator
- YIBO 50.45
- IGMS 8.33
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under four brands, TrueImage, CoolToner, AZtech, and Toner Bank. The company operates in North America, Europe, and Other countries.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.